248 related articles for article (PubMed ID: 25116798)
1. Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization.
Yang J; Li Z; Fan X; Cheng Y
J Chem Inf Model; 2014 Sep; 54(9):2562-9. PubMed ID: 25116798
[TBL] [Abstract][Full Text] [Related]
2. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.
Chen H; Zhang Z
Biomed Res Int; 2015; 2015():406463. PubMed ID: 25789319
[TBL] [Abstract][Full Text] [Related]
3. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
4. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.
Cheng F; Li W; Wu Z; Wang X; Zhang C; Li J; Liu G; Tang Y
J Chem Inf Model; 2013 Apr; 53(4):753-62. PubMed ID: 23527559
[TBL] [Abstract][Full Text] [Related]
5. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
[TBL] [Abstract][Full Text] [Related]
6. Pathway-based drug repositioning using causal inference.
Li J; Lu Z
BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S3. PubMed ID: 24564553
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
Le DH; Nguyen-Ngoc D
Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
[TBL] [Abstract][Full Text] [Related]
8. [Causality in urologic research].
Carrasco Asenjo M
Arch Esp Urol; 2003; 56(6):577-88. PubMed ID: 12958992
[TBL] [Abstract][Full Text] [Related]
9. Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion.
Deepthi K; Jereesh AS
Mol Genet Genomics; 2020 Sep; 295(5):1305-1314. PubMed ID: 32583015
[TBL] [Abstract][Full Text] [Related]
10. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
Wang X; Yan R
J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
[TBL] [Abstract][Full Text] [Related]
11. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
Iwata H; Sawada R; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
[TBL] [Abstract][Full Text] [Related]
12. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
Chen H; Zhang Z; Zhang J
BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
[TBL] [Abstract][Full Text] [Related]
13. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.
Reay WR; El Shair SI; Geaghan MP; Riveros C; Holliday EG; McEvoy MA; Hancock S; Peel R; Scott RJ; Attia JR; Cairns MJ
Elife; 2021 Mar; 10():. PubMed ID: 33720009
[TBL] [Abstract][Full Text] [Related]
14. Pathway-based Bayesian inference of drug-disease interactions.
Pratanwanich N; Lió P
Mol Biosyst; 2014 Jun; 10(6):1538-48. PubMed ID: 24695945
[TBL] [Abstract][Full Text] [Related]
15. Drug repositioning using drug-disease vectors based on an integrated network.
Lee T; Yoon Y
BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
[TBL] [Abstract][Full Text] [Related]
16. Predicting drug-target interactions using probabilistic matrix factorization.
Cobanoglu MC; Liu C; Hu F; Oltvai ZN; Bahar I
J Chem Inf Model; 2013 Dec; 53(12):3399-409. PubMed ID: 24289468
[TBL] [Abstract][Full Text] [Related]
17. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
18. Predicting adverse drug events using pharmacological network models.
Cami A; Arnold A; Manzi S; Reis B
Sci Transl Med; 2011 Dec; 3(114):114ra127. PubMed ID: 22190238
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning for enzyme modulator based on human metabolite-likeness.
Lee YH; Choi H; Park S; Lee B; Yi GS
BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning based on triangularly balanced structure for tissue-specific diseases in incomplete interactome.
Yu L; Zhao J; Gao L
Artif Intell Med; 2017 Mar; 77():53-63. PubMed ID: 28545612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
